Picture of Tristel logo

TSTL Tristel News Story

0.000.00%
gb flag iconLast trade - 00:00
HealthcareAdventurousSmall CapHigh Flyer

RCS - Tristel PLC - Conference attendance at ShareSoc Leeds

For best results when printing this announcement, please click on link below:
https://newsfile.refinitiv.com/getnewsfile/v1/story?guid=urn:newsml:reuters.com:20260318:nRSR9697Wa&default-theme=true

RNS Number : 9697W  Tristel PLC  18 March 2026

 

Tristel plc

("Tristel" or the "Company")

 

Conference attendance at ShareSoc Leeds

 

Tristel plc (AIM: TSTL), the manufacturer of infection prevention products,
announces that Tristel will be presenting at the ShareSoc Growth Company
investor event on 14 April 2026, which will be held at Clayton Hotel, City
Walk, Sweet Street, Leeds, LS11 9AT.

 

Anna Wasyl, CFO of Tristel plc, will present an overview of the Company and
strategy. No new information will be disclosed at the event and a PDF of the
presentation will be made available on the Company's website
at  https://investors.tristel.com/investor-hub/
(https://investors.tristel.com/investor-hub/) .

 

For further information and to register for ShareSoc, please visit the event
website at
https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-person-event-leeds-2/
(https://www.sharesoc.org/events/sharesoc-growth-company-seminar-in-person-event-leeds-2/)
.

 

For further information please contact:

 

 Tristel plc                                                                   Via Walbrook PR
 Matt Sassone, Chief Executive Officer                                         www.investors.tristel.com (https://investors.tristel.com/)
 Anna Wasyl, Chief Financial Officer

 Walbrook PR Ltd             Tel: 020 7933 8780 or tristel@walbrookpr.com
                             (mailto:tristel@walbrookpr.com?subject=tristel@walbrookpr.com)
 Paul McManus / Lianne Applegarth / Anna Dunphy          Mob: 07980 541 893/ 07584 391 303/ 07876 741 001

 Cavendish Capital Markets Ltd                                                 Tel: 020 7220 0500
 Geoff Nash / Callum Davidson / Joe Smith (Corporate Finance)
 Sunila de Silva (Corporate Broking) / Louise Talbot (Sales)

 

About Tristel plc

 

Tristel plc is a global infection prevention company focussed on the
manufacture and supply of products using its unique proprietary chlorine
dioxide (ClO(2)) chemistry. The Company is a market leader in manual
decontamination of medical devices, supplying hospitals under the Tristel
(https://tristel.com/) brand, and under the Cache
(https://thecachecollection.com/) brand provides products for sporicidal
surface disinfection, in a format which is a sustainable alternative to
commonly used pre-wetted plastic wipes.

 

Tristel's head office and manufacturing facility is located in Snailwell, near
Cambridge, and operates globally employing approximately 250 people across 14
subsidiaries selling into 40 countries.

 

The Company has been listed on the London Stock Exchange's AIM market since
2005 (AIM: TSTL).

 

For more information about Tristel's product range please visit:
https://tristel.com (https://tristel.com)

 

 

This information is provided by Reach, the non-regulatory press release distribution service of RNS, part of the London Stock Exchange. Terms and conditions relating to the use and distribution of this information may apply. For further information, please contact
rns@lseg.com (mailto:rns@lseg.com)
 or visit
www.rns.com (http://www.rns.com/)
.

RNS may use your IP address to confirm compliance with the terms and conditions, to analyse how you engage with the information contained in this communication, and to share such analysis on an anonymised basis with others as part of our commercial services. For further information about how RNS and the London Stock Exchange use the personal data you provide us, please see our
Privacy Policy (https://www.lseg.com/privacy-and-cookie-policy)
.   END  NRAJRMLTMTJBMLF



            Copyright 2019 Regulatory News Service, all rights reserved

Recent news on Tristel

See all news